CTMS Evolution: Adapting to Advancements in Clinical Trials

Presented by

Remarque Systems - Meghan Donahue, Product Owner

About this talk

Clinical trial management systems, the software tools that underpin modern clinical research, have evolved dramatically since CTMS technology debuted about 20 years ago and since 2011, when Pfizer conducted the first entirely web-based trial. Still, the systems the industry largely relies on today are outdated and in need of modernization. This webinar examines the evolution and impact of decentralized clinical trials — how these trends are vastly increasing the volume of study data and the sources from which it originates. It illustrates why it is imperative that the systems used to manage clinical trials evolve as well. CTMS must support all modern clinical research processes and manage their growing complexity, a goal supported by the launch in 2020 of the Decentralized Trials & Research Alliance, a non-profit that promotes collaboration to accelerate adoption of patient-focused, decentralized trials and research. This webinar illustrates how a modern CTMS that adapts to industry trends, such as decentralized trials and technology advancements, is essential for optimizing the clinical research process. Key Learning Objectives: - Examine the evolution and impact of decentralized clinical trials - Illustrate why it is imperative that the systems used to manage trials evolve - Explain the importance of supporting all modern clinical research processes and managing their complexities

Related topics:

More from this channel

Upcoming talks (2)
On-demand talks (76)
Subscribers (3167)
Premier Research is a clinical research company, dedicated to helping biotech, specialty pharma, and device innovators transform life-changing ideas and breakthrough science into new medical treatments. As a global company, Premier specializes in the use of innovative technologies for smart study design and trial management to deliver clean, conclusive data to sponsors. Whether it’s developing product lifecycle strategies, reducing clinical development cycle times, securing access to patients, navigating global regulations, maximizing the impact of limited rare disease data, or providing expertise in specific therapeutic areas, Premier is committed to helping its customers answer the unmet needs of patients across a broad range of medical conditions.